Literature DB >> 24647558

Social cognition in pediatric-onset multiple sclerosis (MS).

L E Charvet1, R E Cleary2, K Vazquez2, A L Belman2, L B Krupp2.   

Abstract

BACKGROUND: Pediatric-onset multiple sclerosis (MS) patients represent a subpopulation who are diagnosed during the course of development. Social cognitive deficits have recently been recognized in adults with MS. It is critical to identify whether these youngest patients with the disorder are also at risk.
OBJECTIVE: To determine whether pediatric-onset MS is associated with social cognitive deficits.
METHODS: Consecutively-recruited participants with pediatric-onset MS were compared to a group of age- and gender-matched healthy controls on Theory of Mind (ToM) task performance. Tasks measured facial affect recognition (Reading the Mind in the Eyes Test), detecting social faux pas (Faux Pas Test), and understanding the perspective of another (False Beliefs Task).
RESULTS: Twenty-eight (28) pediatric-onset MS participants (median age 17 years) and 32 healthy controls (median age 16 years) completed the study. The MS participants performed worse than controls on all three ToM tasks: Reading the Mind in the Eyes Test (p = 0.008), the Faux Pas Test (p = 0.009), and the False Beliefs Task (p = 0.06). While more MS than control participants were impaired on a measure of information processing speed (the Symbol Digit Modalities Test; 38% versus 6%), it did not account for the differences in ToM performance.
CONCLUSIONS: Social cognition may represent an area of cognitive functioning affected by MS in the pediatric-onset population. These processes are especially important to study in younger patients as they may have long range implications for social adjustment, employment, and well-being.
© The Author(s) 2014.

Entities:  

Keywords:  Pediatric; cognition; multiple sclerosis; social cognition; theory of mind

Mesh:

Year:  2014        PMID: 24647558      PMCID: PMC4169354          DOI: 10.1177/1352458514526942

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  27 in total

1.  Specific impairments of emotion perception in multiple sclerosis.

Authors:  Louise H Phillips; Julie D Henry; Clare Scott; Fiona Summers; Maggie Whyte; Moira Cook
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

Review 2.  The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis.

Authors:  Anne-Kathrin J Fett; Wolfgang Viechtbauer; Maria-de-Gracia Dominguez; David L Penn; Jim van Os; Lydia Krabbendam
Journal:  Neurosci Biobehav Rev       Date:  2010-07-08       Impact factor: 8.989

3.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

4.  An exploratory study on emotion recognition in patients with a clinically isolated syndrome and multiple sclerosis.

Authors:  Margit Jehna; Christa Neuper; Katja Petrovic; Mirja Wallner-Blazek; Reinhold Schmidt; Siegrid Fuchs; Franz Fazekas; Christian Enzinger
Journal:  Clin Neurol Neurosurg       Date:  2010-04-15       Impact factor: 1.876

5.  Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces.

Authors:  Margit Jehna; Christian Langkammer; Mirja Wallner-Blazek; Christa Neuper; Marisa Loitfelder; Stefan Ropele; Siegrid Fuchs; Michael Khalil; Aga Pluta-Fuerst; Franz Fazekas; Christian Enzinger
Journal:  Brain Imaging Behav       Date:  2011-12       Impact factor: 3.978

6.  The children's Empathy Quotient and Systemizing Quotient: sex differences in typical development and in autism spectrum conditions.

Authors:  Bonnie Auyeung; Sally Wheelwright; Carrie Allison; Matthew Atkinson; Nelum Samarawickrema; Simon Baron-Cohen
Journal:  J Autism Dev Disord       Date:  2009-06-17

7.  Evidence for deficits in facial affect recognition and theory of mind in multiple sclerosis.

Authors:  Julie D Henry; Louise H Phillips; William W Beatty; Skye McDonald; Wendy A Longley; Amy Joscelyne; Peter G Rendell
Journal:  J Int Neuropsychol Soc       Date:  2009-02-10       Impact factor: 2.892

Review 8.  Social cognition in neurodegenerative disorders: a systematic review.

Authors:  Marwa Elamin; Niall Pender; Orla Hardiman; S Abrahams
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-08-06       Impact factor: 10.154

9.  Prefrontal function associated with impaired emotion recognition in patients with multiple sclerosis.

Authors:  Matthias Krause; Julia Wendt; Alexander Dressel; Julia Berneiser; Christof Kessler; Alfons O Hamm; Martin Lotze
Journal:  Behav Brain Res       Date:  2009-08-15       Impact factor: 3.332

10.  Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.

Authors:  B Brochet; M S A Deloire; M Bonnet; E Salort-Campana; J C Ouallet; K G Petry; V Dousset
Journal:  Mult Scler       Date:  2008-07-24       Impact factor: 6.312

View more
  10 in total

Review 1.  Social Cognition in Multiple Sclerosis: a Meta-Analysis.

Authors:  Emre Bora; Serkan Özakbaş; Dennis Velakoulis; Mark Walterfang
Journal:  Neuropsychol Rev       Date:  2016-06-20       Impact factor: 7.444

2.  A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.

Authors:  A Ghezzi; A Bianchi; D Baroncini; A Bertolotto; S Malucchi; V Bresciamorra; R Lanzillo; N Milani; V Martinelli; F Patti; C Chisari; M Rottoli; M Simone; D Paolicelli; A Visconti
Journal:  Neurol Sci       Date:  2017-08-22       Impact factor: 3.307

3.  Labelling Facial Affect in Context in Adults with and without TBI.

Authors:  Lyn S Turkstra; Sarah G Kraning; Sarah K Riedeman; Bilge Mutlu; Melissa Duff; Sara VanDenHeuvel
Journal:  Brain Impair       Date:  2016-12-13       Impact factor: 1.727

4.  Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis.

Authors:  Cecile Dulau; Mathilde Deloire; Helene Diaz; Aurore Saubusse; Julie Charre-Morin; Antoinette Prouteau; Bruno Brochet
Journal:  J Neurol       Date:  2017-02-20       Impact factor: 4.849

5.  No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.

Authors:  Monica Margoni; Francesca Rinaldi; Alice Riccardi; Silvia Franciotta; Paola Perini; Paolo Gallo
Journal:  J Neurol       Date:  2019-09-27       Impact factor: 4.849

Review 6.  Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis.

Authors:  Marisa McGinley; Ian T Rossman
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 7.  Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic, and Neuroradiologic Features.

Authors:  Ozgul Ekmekci
Journal:  Behav Neurol       Date:  2017-12-25       Impact factor: 3.342

8.  Cognitive Functioning in Patients with Pediatric-Onset Multiple Sclerosis, an Updated Review and Future Focus.

Authors:  Joy B Parrish; Emily Fields
Journal:  Children (Basel)       Date:  2019-02-04

Review 9.  Social cognition in multiple sclerosis: A systematic review and meta-analysis.

Authors:  Jack Cotter; Joseph Firth; Christian Enzinger; Evangelos Kontopantelis; Alison R Yung; Rebecca Elliott; Richard J Drake
Journal:  Neurology       Date:  2016-09-21       Impact factor: 9.910

10.  Social cognition in multiple sclerosis and its subtypes: A protocol for systematic review and meta-analysis.

Authors:  XiaoGuang Lin; XueLing Zhang; QinQin Liu; PanWen Zhao; JianGuo Zhong; PingLei Pan; GenDi Wang; ZhongQuan Yi
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.